Fierce Healthcare April 1, 2021
The American Medical Association innovation subsidiary Health2047 has spun off a company that uses personalized medicine to fight obesity.
Phenomix Sciences is a phenotype testing company that carries out the AMA’s mission to confront chronic diseases such as obesity.
Phenomix uses a blood test called MyPhenome that it has licensed from the Mayo Clinic to allow doctors to prescribe individualized therapies. MyPhenome measures DNA as well as a person’s metabolites and hormones. These biomarkers make up a person’s phenotype, according to Phenomix.
A 2020 Columbia University study found that 60% of people who were extremely obese were more likely to require ventilation or pass away from COVID-19. Overall, 42% of American adults live with obesity, according to a report by...
Today's Sponsors
Today's Sponsor